Stevens L M, Hughes D C, Davis P L. "Method for the Synthesis of 5-Methyl-4-{6-methylimidazo[1,2-a]pyridin-2-yl}-1,2-oxazole" [P]. US Patent, US 9308243 B2, 2024-08-20.
发明人周伟,孙丽萍,郑宇鹏. "A Process for Preparing High-Purity 5-Methyl-4-{6-methylimidazo[1,2-a]pyridin-2-yl}-1,2-oxazole" [P]. 中国发明专利, 专利号 CN 110603727 B, 授权公告日 2025-08-20.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2014, 1916, (5), 892-911.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2024, 2185, (12), 3011-3035.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 5-Methyl-4-{6-methylimidazo[1,2-a]pyridin-2-yl}-1,2-oxazole Using HRMS and NMR". Phytochemistry, 2015, 1256, (8), 9408-9428.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2021, 1356, (7), 6076-6086.